Study rates every state’s telehealth laws for patient access and ease of providing services

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Los Angeles (Jan. 5, 2022) — A new report from Reason Foundation, Cicero Institute and Pioneer Institute rates every state’s telehealth policy for patient access and ease of providing virtual care.

Millions of Americans tried telehealth for the first time last year as federal officials and governors temporarily lifted restrictions that limited patient access to virtual care. But many of these restrictions on practices like speaking with doctors across state lines, recording voice messages with care instructions, and mandating insurance coverage have been reinstated, the new report finds.

“Once the public health emergency declarations started to end or executive orders were withdrawn many of the new flexibilities for providers, insurers, and patients were lost overnight,” says Vittorio Nastasi, policy analyst at Reason Foundation and co-author of the report. “States need to adopt a number of telehealth reforms to provide their residents better access to this safe and effective virtual care.”

Nationally, the study finds that several states that have been hardest hit by the pandemic have the most restrictive telehealth laws. These states include New York, California, and Connecticut which have not signed up for interstate licensing compacts and have coverage parity mandates that offer no flexibility between the insurer and provider.

Only three states — Arizona, Florida, and Indiana — allow all providers to easily practice telehealth across state lines. Forty-seven others have arbitrary barriers in place that limit patients’ access to specialists and available appointments based purely on residency.

On a positive note, almost all states have removed the requirement that a patient must first see a provider in-person before they can use telehealth services, the exception being Tennessee, while Alaska and West Virginia require an in-person visit before certain services can be provided. Another 20 states allow full independent practice for nurse practitioners without the supervision of a physician.

The report highlights telehealth policy best practices for states. “While they cannot and should not replace all in-person medical appointments, virtual visits can save patients time and help them avoid germ-filled waiting rooms. Providers can also take some pressure off overburdened systems as they can see patients from an office or home,” writes report co-author Josh Archambault, a senior fellow with Cicero Institute and Pioneer Institute.

The full report with state rankings is available online from Pioneer Institute, Reason Foundation, and Cicero Institute.

Contact

Allison Tierney, Communications Specialist, Reason Foundation, 616.550.5769, allison.tierney@reason.org

Get Updates On Our Healthcare Research and Events!

Related Posts:

Is this PBM tactic blocking healthcare access?

Utilization Management (UM) was originally a strategy designed to improve the safety, quality, and cost-effectiveness of physician prescribing. However, UM has grown exponentially over the last decade, becoming more a tactic for Pharmacy Benefit Managers (PBMs) to manage costs to benefit their bottom line.

Drug Price Control: Bad Medicine for Healthcare and Region

Hubwonk host Joe Selvaggi talks with Dr. Bill Smith, Director of Pioneer Institute’s Life Sciences Initiative, about the impact of the Inflation Reduction Act on long-term health costs. They discuss the bill's unintended consequences, potential effect on the region’s vibrant pharmaceutical research and development sector, and what citizens can do about it.

The Realities Behind US Healthcare Spending

Healthcare policy is an all-encompassing term. It plays a role in every individual’s life; how it is curated, developed, and maintained has a significant long-term impact on the quality of life of any given community. It is critical that policymakers consistently adapt and amend healthcare policies in the ever-changing global pricing and affordability environment while providing funding support for optimal quality of care.

Healthcare dominates the job market.

/
Healthcare and social assistance are among the most important…

Drug Cost Disruption: Direct Generic Access Can Save Consumers Billions

Hubwonk host Joe Selvaggi talks with Dr. Hussain Lalani about his recently published research on the potential for more than $3 billion in savings were Medicare to use Mark Cuban’s new direct-to-consumer drug company to purchase generics.
This file is licensed under the Creative Commons Attribution 2.0 Generic license.

Healthcare Employs More on Cape Cod Than Any Other Sector

/
Despite being a major tourist destination, the largest employment sector on Cape Cod is not related to tourism: it is healthcare!

Doctors With Borders: Curing Shortages With International Lifeline

This week on Hubwonk, host Joe Selvaggi talks with Cicero Institute’s Jonathan Wolfson about the growing doctor shortage and the potential to alleviate the crisis by tapping the global supply of well-trained physicians eager to find safety and freedom in the US.

Pharmacy Benefit Profiteers: Distortions and Costs of Half-Trillion Dollar Drug Middlemen

Hubwonk Host Joe Selvaggi talks with ALVA10 Chief Executive Hannah Mamuszka and Dr. Blake Long about the perverse incentives imposed by Pharmacy Benefit Managers adding nearly $500 billion to U.S. drug costs.

Exploiting Charity Drugs: Hospital Program Earns Billions But Forgets Mission

Hubwonk host Joe Selvaggi talks with Pioneer Institute’s Dr. Bill Smith about his recently released paper entitled, "340B Drug Discounts, An Increasingly Dysfunctional Federal Program," which analyzes the evolution of a well-intentioned program to offer discounted drugs to the uninsured from a benefit that had helped charitable hospitals to one that has exploded to generate billions in profits while serving fewer uninsured.

Massachusetts Hospitals Pull Back on Charity Care as Revenue from Federal 340B Drug Discount Program Explodes

Over the past decade, the revenue for hospitals generated by the federal 340B drug discount program, initially intended to serve low-income, uninsured populations, has exploded even while a number of important Massachusetts hospitals have reduced the level of charity care they provide, according to a new study published by Pioneer Institute. The Pioneer Institute study, “340B Drug Discounts: An Increasingly Dysfunctional Program,” notes that nationwide, 340B drug sales rose from $9 billion in 2014 to $38 billion in 2020.